GNI Group Ltd. (TYO:2160)
Japan · Delayed Price · Currency is JPY 2,602.00
+22.00 (0.85%)
Jul 15, 2026, 3:30 PM JST
GNI Group Market Cap
GNI Group has a market cap or net worth of 171.21 billion as of July 15, 2026. Its market cap has decreased by -8.46% in one year.
Market Cap
171.21B
Enterprise Value
157.01B
Revenue
27.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,602.00
Market Cap Chart
Since August 31, 2007, GNI Group's market cap has increased from 5.24B to 171.21B, an increase of 3,170.10%. That is a compound annual growth rate of 20.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 171.21B | 27.54% |
| Dec 30, 2025 | 134.25B | -21.38% |
| Dec 30, 2024 | 170.75B | 21.35% |
| Dec 29, 2023 | 140.72B | 112.73% |
| Dec 30, 2022 | 66.15B | -5.89% |
| Dec 30, 2021 | 70.29B | -10.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PeptiDream | 129.33B |
| Nxera Pharma | 84.09B |
| SanBio Company | 78.68B |
| Oncolys BioPharma | 73.26B |
| Cuorips | 38.98B |
| Healios K.K. | 35.24B |
| Japan Tissue Engineering | 26.80B |
| Renascience | 22.46B |